| PERIOD ENDING | 31-Dec-08 | | Total Revenue | 15,574 | | Cost of Revenue |
-
| | | Gross Profit | 15,574 | | | Operating Expenses | | Research Development | 9,119 | | Selling General and Administrative | 6,493 | | Non Recurring | 2,502 | | Others | 682 | | | | Total Operating Expenses | 18,796 | | | | Operating Income or Loss | (3,222) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 312 | | Earnings Before Interest And Taxes | (2,910) | | Interest Expense | 5 | | Income Before Tax | (2,915) | | Income Tax Expense |
-
| | Minority Interest |
-
| | | | Net Income From Continuing Ops | (2,915) | | | Non-recurring Events | | Discontinued Operations |
-
| | Extraordinary Items |
-
| | Effect Of Accounting Changes |
-
| | Other Items |
-
| | | | Net Income | (2,915) | | Preferred Stock And Other Adjustments |
-
| | | Net Income Applicable To Common Shares | ($2,915) |
|
0.47% Nasdaq 
Income Statement
